83 FR 60895 - Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest

INTERNATIONAL TRADE COMMISSION

Federal Register Volume 83, Issue 228 (November 27, 2018)

Page Range		60895-60896
FR Document		2018-25749

Notice is hereby given that the U.S. International Trade Commission has received a complaint entitled Certain Cartridges for Electronic Nicotine Delivery Systems and Components Thereof, DN 3354; the Commission is soliciting comments on any public interest issues raised by the complaint or complainant's filing pursuant to the Commission's Rules of Practice and Procedure.

Federal Register, Volume 83 Issue 228 (Tuesday, November 27, 2018)

[Federal Register Volume 83, Number 228 (Tuesday, November 27, 2018)]
[Notices]
[Pages 60895-60896]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-25749]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION


Notice of Receipt of Complaint; Solicitation of Comments Relating 
to the Public Interest

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has received a complaint entitled Certain Cartridges for 
Electronic Nicotine Delivery Systems and Components Thereof, DN 3354; 
the Commission is soliciting comments on any public interest issues 
raised by the complaint or complainant's filing pursuant to the 
Commission's Rules of Practice and Procedure.

FOR FURTHER INFORMATION CONTACT: Lisa R. Barton, Secretary to the 
Commission, U.S. International Trade Commission, 500 E Street SW, 
Washington, DC 20436, telephone (202) 205-2000. The public version of 
the complaint can be accessed on the Commission's Electronic Document 
Information System (EDIS) at https://edis.usitc.gov, and will be 
available for inspection during official business hours (8:45 a.m. to 
5:15 p.m.) in the Office of the Secretary, U.S. International Trade 
Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205-
2000.
    General information concerning the Commission may also be obtained 
by accessing its internet server at United States International Trade 
Commission (USITC) at https://www.usitc.gov. The public record for this 
investigation may be viewed on the Commission's Electronic Document 
Information System (EDIS) at https://edis.usitc.gov. Hearing-impaired 
persons are advised that information on this matter can be obtained by 
contacting the Commission's TDD terminal on (202) 205-1810.

SUPPLEMENTARY INFORMATION: The Commission has received a complaint and 
a submission pursuant to Sec.  210.8(b) of the Commission's Rules of 
Practice and Procedure filed on behalf of Juul Labs, Inc., on November 
20, 2018. The complaint alleges violations of section 337 of the Tariff 
Act of 1930 (19 U.S.C. 1337) in the importation into the United States, 
the sale for importation, and the sale within the United States after 
importation of certain cartridges for electronic nicotine delivery 
systems and components thereof. The complaint names as respondents: 
DripTip Vapes LLC of Plantation, FL; The Electric Tobacconist, LLC of 
Boulder, CO; Fuma Vapor, Inc. of Des Plaines, IL; Lan & Mike 
International Trading, Inc. of Torrance, CA; Lizard Juice, LLC of 
Largo, FL; Maduro Distributors, Inc. of Maplewood, MN; MistHub, LLC of 
Buffalo Grove, IL; Noah Duvberg of Daytona Beach, FL; ParallelDirect 
LLC of Lincolnshire, IL; Saddam Aburoumi of Manchester, CT; Sarvasva 
LLC of Maple Shade, NJ; Shenzhen Haka Flavor Technology Co., Ltd. of 
China; Shenzhen OCIGA Technology Co., Ltd. of China; Shenzhen OVNS 
Technology Co., Ltd. of China; Shenzhen Yibo Technology Co., Ltd. of 
China; Twist Vapor Franchising, LLC of Tampa, FL; United Wholesale LLC 
of Glastonbury, CT; Vape4U LLC of Montclair, CA; Vaperz LLC of 
Frankfort, IL; Vaportronix, LLC of Aventura, FL; Vapor 4 Life Holdings, 
Inc. of Northbrook, IL; The ZFO of Spencerport, NY; Zipp Lab Co. Ltd. 
of China; and Ziip Lab S.A. of Uruguay. The complainant requests that 
the Commission issue a limited exclusion order and cease and desist 
orders and impose a bond during the 60-day review period pursuant to 19 
U.S.C. 1337(j).
    Proposed respondents, other interested parties, and members of the 
public are invited to file comments, not to exceed five (5) pages in 
length, inclusive of attachments, on any public interest issues raised 
by the complaint or Sec.  210.8(b) filing. Comments should address 
whether issuance of the relief specifically requested by the 
complainant in this investigation would affect the public health and 
welfare in the United States, competitive conditions in the United 
States economy, the production of like or directly competitive articles 
in the United States, or United States consumers.
    In particular, the Commission is interested in comments that:
    (i) Explain how the articles potentially subject to the requested 
remedial orders are used in the United States;
    (ii) identify any public health, safety, or welfare concerns in the 
United States relating to the requested remedial orders;
    (iii) identify like or directly competitive articles that 
complainant, its licensees, or third parties make in the United States 
which could replace the subject articles if they were to be excluded;
    (iv) indicate whether complainant, complainant's licensees, and/or 
third party suppliers have the capacity to replace the volume of 
articles potentially subject to the requested exclusion order and/or a 
cease and desist order within a commercially reasonable time; and
    (v) explain how the requested remedial orders would impact United 
States consumers.
    Written submissions on the public interest must be filed no later 
than by close of business, eight calendar days after the date of 
publication of this notice in the Federal Register. There will be 
further opportunities for comment on the public interest after the 
issuance of any final initial determination in this investigation. Any 
written submissions on other issues should be filed no later than by 
close of business nine calendar days after the date of publication of 
this notice in the Federal Register. Complainant may file a reply to 
any written submission no later than the date on which complainant's 
reply would be due under Sec.  210.8(c)(2) of the Commission's Rules of 
Practice and Procedure (19 CFR 210.8(c)(2)).
    Persons filing written submissions must file the original document 
electronically on or before the deadlines stated above and submit 8 
true paper copies to the Office of the Secretary by noon the next day 
pursuant to Sec.  210.4(f) of the Commission's Rules of Practice and 
Procedure (19 CFR 210.4(f)). Submissions should refer to the docket 
number (``Docket No. 3354) in a prominent place on the cover page and/
or the first page. (See Handbook for Electonic Filing Procedures, 
Electronic Filing Procedures).\1\ Persons with questions regarding 
filing should contact the Secretary (202-205-2000).
---------------------------------------------------------------------------

    \1\ Handbook for Electronic Filing Procedures: https://www.usitc.gov/documents/handbook_on_filing_procedures.pdf.
---------------------------------------------------------------------------

    Any person desiring to submit a document to the Commission in 
confidence must request confidential treatment. All such requests 
should be

[[Page 60896]]

directed to the Secretary to the Commission and must include a full 
statement of the reasons why the Commission should grant such 
treatment. See 19 CFR 201.6. Documents for which confidential treatment 
by the Commission is properly sought will be treated accordingly. All 
such requests should be directed to the Secretary to the Commission and 
must include a full statement of the reasons why the Commission should 
grant such treatment. See 19 CFR 201.6. Documents for which 
confidential treatment by the Commission is properly sought will be 
treated accordingly. All information, including confidential business 
information and documents for which confidential treatment is properly 
sought, submitted to the Commission for purposes of this Investigation 
may be disclosed to and used: (i) By the Commission, its employees and 
Offices, and contract personnel (a) for developing or maintaining the 
records of this or a related proceeding, or (b) in internal 
investigations, audits, reviews, and evaluations relating to the 
programs, personnel, and operations of the Commission including under 5 
U.S.C. Appendix 3; or (ii) by U.S. government employees and contract 
personnel,\2\ solely for cybersecurity purposes. All nonconfidential 
written submissions will be available for public inspection at the 
Office of the Secretary and on EDIS.\3\
---------------------------------------------------------------------------

    \2\ All contract personnel will sign appropriate nondisclosure 
agreements.
    \3\ Electronic Document Information System (EDIS): https://edis.usitc.gov.
---------------------------------------------------------------------------

    This action is taken under the authority of section 337 of the 
Tariff Act of 1930, as amended (19 U.S.C. 1337), and of Sec. Sec.  
201.10 and 210.8(c) of the Commission's Rules of Practice and Procedure 
(19 CFR 201.10, 210.8(c)).

    By order of the Commission.
    Issued: November 20, 2018.
Katherine M. Hiner,
Supervisory Attorney.
[FR Doc. 2018-25749 Filed 11-26-18; 8:45 am
 BILLING CODE 7020-02-P

60896 Federal Register / Vol. 83, No. 228 / Tuesday, November 27, 2018 / Notices

directed to the Secretary to the of this or a related proceeding, or (b) in DEPARTMENT OF JUSTICE
Commission and must include a full internal investigations, audits, reviews,
statement of the reasons why the and evaluations relating to the Drug Enforcement Administration
Commission should grant such programs, personnel, and operations of
[Docket No. DEA–392]
treatment. See 19 CFR 201.6. Documents the Commission including under 5
for which confidential treatment by the U.S.C. Appendix 3; or (ii) by U.S. Importer of Controlled Substances
Commission is properly sought will be government employees and contract Registration
treated accordingly. All such requests personnel,2 solely for cybersecurity
should be directed to the Secretary to purposes. All nonconfidential written ACTION: Notice of registration.
the Commission and must include a full submissions will be available for public
statement of the reasons why the inspection at the Office of the Secretary SUMMARY: The registrant listed below
Commission should grant such and on EDIS.3 has applied for and been granted
treatment. See 19 CFR 201.6. Documents registration by the Drug Enforcement
This action is taken under the
for which confidential treatment by the Administration (DEA) as an importer of
authority of section 337 of the Tariff Act
Commission is properly sought will be various classes of schedule I or II
of 1930, as amended (19 U.S.C. 1337),
treated accordingly. All information, controlled substances.
and of §§ 201.10 and 210.8(c) of the
including confidential business Commission’s Rules of Practice and SUPPLEMENTARY INFORMATION: The
information and documents for which Procedure (19 CFR 201.10, 210.8(c)). company listed below applied to be
confidential treatment is properly registered as an importer of various
sought, submitted to the Commission for By order of the Commission. basic classes of controlled substances.
Issued: November 20, 2018.
purposes of this Investigation may be Information on the previously published
disclosed to and used: (i) By the Katherine M. Hiner, notice is listed in the table below. No
Commission, its employees and Offices, Supervisory Attorney. comments or objections were submitted
and contract personnel (a) for [FR Doc. 2018–25749 Filed 11–26–18; 8:45 am and no requests for hearing were
developing or maintaining the records BILLING CODE 7020–02–P submitted for this notice.

Company FR Docket Published

Clinical Supplies Management Holdings, Inc ......................... 83 FR 39127 .......................................................................... August 08, 2018.

The DEA has considered the factors in DEPARTMENT OF JUSTICE Drive, Springfield, Virginia 22152; and
21 U.S.C. 823, 952(a) and 958(a) and (2) Drug Enforcement Administration,
determined that the registration of the Drug Enforcement Administration Attn: DEA Federal Register
listed registrant to import the applicable Representative/DPW, 8701 Morrissette
[Docket No. DEA–392]
basic class of schedule I controlled Drive, Springfield, Virginia 22152.
substance is consistent with the public Importer of Controlled Substances SUPPLEMENTARY INFORMATION: The
interest and with United States Application: Akorn, Inc. Attorney General has delegated his
obligations under international treaties, authority under the Controlled
conventions, or protocols in effect on ACTION: Notice of application. Substances Act to the Administrator of
May 1, 1971. The DEA investigated the the Drug Enforcement Administration
company’s maintenance of effective DATES: Registered bulk manufacturers of (DEA), 28 CFR 0.100(b). Authority to
controls against diversion by inspecting the affected basic classes, and exercise all necessary functions with
applicants therefore, may file written respect to the promulgation and
and testing the company’s physical
comments on or objections to the implementation of 21 CFR part 1301,
security systems, verifying the
issuance of the proposed registration on incident to the registration of
company’s compliance with state and
or before December 27, 2018 Such manufacturers, distributors, dispensers,
local laws, and reviewing the company’s persons may also file a written request
background and history. importers, and exporters of controlled
for a hearing on the application on or substances (other than final orders in
Therefore, pursuant to 21 U.S.C. before December 27, 2018. connection with suspension, denial, or
952(a) and 958(a), and in accordance ADDRESSES: Written comments should revocation of registration) has been
with 21 CFR 1301.34, the DEA has be sent to: Drug Enforcement redelegated to the Assistant
granted a registration as an importer for Administration, Attention: DEA Federal Administrator of the DEA Diversion
schedule I controlled substances to the Register Representative/DPW, 8701 Control Division (‘‘Assistant
above listed company. Morrissette Drive, Springfield, Virginia Administrator’’) pursuant to section 7 of
Dated: November 16, 2018. 22152. All requests for hearing must be 28 CFR part 0, appendix to subpart R.
sent to: Drug Enforcement In accordance with 21 CFR
John J. Martin,
Administration, Attn: Administrator, 1301.34(a), this is notice that on May 2,
Assistant Administrator. 8701 Morrissette Drive, Springfield, 2018, Akorn Inc., 1222 W. Grand
[FR Doc. 2018–25866 Filed 11–26–18; 8:45 am] Virginia 22152. All requests for hearing Avenue, Decatur, Illinois 62522 applied
BILLING CODE 4410–09–P should also be sent to: (1) Drug to be registered as an importer of the
amozie on DSK3GDR082PROD with NOTICES1

Enforcement Administration, Attn: following basic class of controlled
Hearing Clerk/OALJ, 8701 Morrissette substance:

2 All contract personnel will sign appropriate 3 Electronic Document Information System

nondisclosure agreements. (EDIS): https://edis.usitc.gov.

VerDate Sep<11>2014 17:45 Nov 26, 2018 Jkt 247001 PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 E:\FR\FM\27NON1.SGM 27NON1

Document Created: 2018-11-27 01:24:43
Document Modified: 2018-11-27 01:24:43

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Contact		Lisa R. Barton, Secretary to the Commission, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205-2000. The public version of the complaint can be accessed on the Commission's Electronic Document Information System (EDIS) at https://edis.usitc.gov, and will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205- 2000.
FR Citation		83 FR 60895